Literature DB >> 1084362

Mouse lymphotoxin.

G Trivers, D Braungart, E J Leonard.   

Abstract

The addition of PHA to C3H mouse spleen cells in tissue culture led to the production of lymphotoxin (LT). Cytotoxicity was assayed by addition of the culture fluids to syngeneic target cells labeled with tritiated thymidine; after an incubation period of 72 hr the amount of radioactivity released into the supernatant was measured. The LT activity in unfractionated culture fluids survived lyophilization, remained unchanged for many weeks at 4 degrees C, and progressively decreased on heating at 56 degrees C for periods from 1 to 9 hr. Based on the G-200 Sephadex distribution coefficients for several preparations, the m.w. of mouse lymphotoxin was about 41,000 daltons. Lymphotoxin from three different spleen cell production runs was recovered from isoelectric focusing columns in sharply focused peaks, the pH of which ranged from 4.4 to 4.8.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084362

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

2.  Production of mouse lymphotoxin by phytohemagglutinin-stimulated spleen cells requires two cell fractions.

Authors:  R R Aksamit; E J Leonard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

3.  Characterization of lectin-induced cellular cytotoxicity mediated by mouse spleen cells and the role of lymphotoxin.

Authors:  J Sawada; T Osawa
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

4.  Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells.

Authors:  D N Männel; M S Meltzer; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

5.  Anti-tumour cytotoxicity of poly(A)-containing messenger RNA isolated from tumour-specific immunogenic RNA.

Authors:  C J Greenup; D A Vallera; K J Pennline; B J Kolodziej; M C Dodd
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.